Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000106

EVP, Chief Technical Ops. Off. sold 668 shares at $486.35 ($324,882)

  • EVP, Chief Technical Ops. Off. gave up 1,627 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −1,627 $485.11 $789,274 19,100 D
2026-02-25 Sale : show line 2 in the form 10b5-1 −668 $486.35 $324,882 18,432 D
Open-market sales · 668 sh · avg $486.35 · $324,882
Loading xslF345X05/wk-form4_1772146808.xml…